Paydirt
KH
Insider

Kate Haviland

CHIEF EXECUTIVE OFFICER

Kate Haviland (CHIEF EXECUTIVE OFFICER) filed 4 Form 4 reports in the past 24 months (0 purchases, 4 sales), most often in BPMC. The largest single filing was $1.4M of BPMC (16,151 sh × $88.80, as filed), executed Mar 5 2025. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.9M
shares × price, as filed
Last traded
Apr 1 2025
Filed Apr 3 2025
Open performance→
Volume by month
$1.4M$717K$0Dec 2024Jun 2025Dec 2025Jun 2026Dec 2024 · sells $169KJan 2025 · sells $159KMar 2025 · sells $1.4MApr 2025 · sells $105K
Buys $0 Sells $1.9M

Shares × price, as filed · by filing month · past 24 months

Most traded names
BPMC BPMC 0 buys · 4 sells 4 filings
Recent filings
BPMCSALE Blueprint Medicines Corp View filing → $105K
1,200 sh × $87.34
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET
BPMCSALE Blueprint Medicines Corp View filing → $1.4M
16,151 sh × $88.80
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET
BPMCSALE Blueprint Medicines Corp View filing → $159K
1,446 sh × $110.24
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET
BPMCSALE Blueprint Medicines Corp View filing → $169K
1,746 sh × $96.74
Exec Nov 29 2024
Filed Dec 3 2024 · 5:30 PM ET